pemetrexed,cisplatin,gemcitabine,pembrolizumab
merck
['lcsm,(-blcsm)']
 &gt; 40% squam in both arms equal splits for pdl1 subgroups small n of egfr/alk+ pcr/mpr didn t affects efs aes as expected (1 death due to pneumonitis)
#asco23 #lcsm 
Chief Hem/Onc Fellow @HFHemOncFellows | #ASCOTrainee council | Former IM Resident @MSU_Medicine | @UJ_MED Alum | #LCSM🫁🧬🎯 | Girl Dad👧🏼 | 🇵🇸🇯🇴🇺🇸